Section Arrow
APGE.NASDAQ
- Apogee Therapeutics
Quotes are at least 15-min delayed:2026/06/21 17:03 EDT
Regular Hours
Last
 90.38
+1.95 (+2.21%)
Day High 
91.03 
Prev. Close
88.43 
1-M High
91.9 
Volume 
1.97M 
Bid
91
Ask
91.8
Day Low
87.4 
Open
91.03 
1-M Low
75 
Market Cap 
6.67B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 86.62 
20-SMA 83.7 
50-SMA 84.62 
52-W High 95.315 
52-W Low 34.34 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.33/-5.14
Enterprise Value
6.67B
Balance Sheet
Book Value Per Share
16.66
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.01+0.0056+127.27%-- 
CDTCDT Equity Inc.1.02+0.327+47.19%-- 
AZTRAzitra0.1717-0.0313-15.42%-- 
CRVOCervoMed4.24+0.43+11.29%-- 
OCGNOcugen1.24+0.01+0.81%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for thetreatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies bytargeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.